Impact of "SI Kumbang" Gymnastic Exercise on Physical Performance and Immunity in the Elderly

NCT ID: NCT07300722

Last Updated: 2025-12-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

66 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-01

Study Completion Date

2025-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to evaluate and compare the impact of SI Kumbang gymnastic exercise and Bugar Lansia gymnastic exercise programs on physical performance dan immunity in elderly. It will also learn about the safety of SI Kumbang gymnastic exercise. The main questions it aims to answer are:

* How does cardiorespiratory fitness differ between SI Kumbang and Bugar Lansia exercise?
* How does muscle strength differ between SI Kumbang and Bugar Lansia exercise?
* How does balance differ between SI Kumbang and Bugar Lansia exercise?
* How does physical activity differ between SI Kumbang and Bugar Lansia exercise?
* How do Caspase-1 and IL-18 inflammasomes differ between SI Kumbang and Bugar Lansia exercise? Researchers will compare SI Kumbang gymnastic exercise to a Bugar Lansia gymnastic exercise to see if SI Kumbang gymnastic exercise better than Bugar Lansia gymnastic exercise.

Participants will:

* Do SI Kumbang gymnastic exercise or Bugar Lansia gymnastic exercise a within 3 times a week for 3 months.
* Visit the clinic twice for outcome assesment before and after intervention.
* Keep a diary of their symptoms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A sample size of 33 people per group was determined. The study supervisor oversaw the use of a basic randomization program to carry out the random allocation. The Sequentially Numbered, Opaque, Sealed Envelope (SNOSE) technique was used to guarantee allocation concealment. Outcome assessors were subjected to single blinding; they were not told about group allocations and were not allowed to look for relevant information. The "SI Kumbang" and "Bugar Lansia" gymnastics exercise regimens were part of the intervention groups. For 12 weeks in a row, both therapies included three 30-minute sessions per week. Participants received adaption sessions to acquaint themselves with the workout regimens throughout the first week. The Borg Scale was utilized to track intensity.

The research team reviewed patient logbooks at the beginning of each week to track adverse effects such weariness, shortness of breath, pain, or dizziness. At RS Islam Jakarta Pondok Kopi, every suspected adverse event was swiftly assessed, and any required medical attention was given. Every adverse event was reported to the ethics committee of the institution.

Data analysis was performed using SPSS 29.0 tests with significance set at p\<0.05. Descriptive summaries of the sample characteristics were provided. Prior to analysis, the normality of the data was checked. Dependent t-tests were used to compare pre intervention and post intervention score in the SI Kumbang and Bugar Lansia groups for normally distributed outcomes (6MWD, handgrip, SPPB, PASE, Caspase-1, IL-18); the Wilcoxon test was used to assess non-normal data. Independent t test or Mann-Whitney U test is used for compared the effectiveness of the two interventions (∆ score). A p-value of less than 0.05 was deemed significant.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

physical performance immunity SI Kumbang exercise gymnastics elderly

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The SI Kumbang gymnastics exercise and Bugar Lansia gymnastics exercise regimens were part of the intervention groups. For 12 weeks in a row, both therapies included three 30-minute sessions, 3 times per week. Participants received adaption sessions to acquaint themselves with the workout regimens throughout the first week. The Borg Scale was utilized to track intensity.
Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SI Kumbang Gymnastic Exercise

Intervention Group received SI Kumbang gymnastic exercise

Group Type EXPERIMENTAL

SI Kumbang gymnastic exercise

Intervention Type OTHER

SI Kumbang Gymnastic Exercise with four-way leg movements with hand movements using barbell weights and medium-intensity music.

Bugar Lansia Gymnastic Exercise

Controlled Group received Bugar Lansia gymnastic exercise

Group Type ACTIVE_COMPARATOR

Bugar Lansia Gymnastic Exercise

Intervention Type OTHER

Bugar Lansia Gymnastic Exercise with one-way forward leg movements with hand movements without barbell weights with medium intensity music.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SI Kumbang gymnastic exercise

SI Kumbang Gymnastic Exercise with four-way leg movements with hand movements using barbell weights and medium-intensity music.

Intervention Type OTHER

Bugar Lansia Gymnastic Exercise

Bugar Lansia Gymnastic Exercise with one-way forward leg movements with hand movements without barbell weights with medium intensity music.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female participants
* Age of 60 to 70 years old.
* Categorized as pre-frail (FI-40 score \> 0.08 \< 0.25) or robust (FI-40 score ≤ 0.08)
* Body mass index (BMI) between 18.5 and 24.9.
* Diabetes mellitus (controlled glucose ≤ 120 mg/dL)
* Blood pressure (controlled blood tension ≤ 130/80 mmHg) without taking any drugs that affected heart rate.

Exclusion Criteria

* Chronic heart or lung disease conditions
* Chronic conditions that cannot be reversed (e.g., cancer or chronic renal disease)
* Diabetes complications in the extremities
* Motor impairment (MMT \< 5)
* Knee pain
* Lower limb deformities (genu varus/valgus)
* Hand deformities
Minimum Eligible Age

60 Years

Maximum Eligible Age

70 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fakultas Kedokteran dan Kesehatan Universitas Muhammadiyah Jakarta

OTHER

Sponsor Role collaborator

Fakultas Kedokteran Universitas Indonesia

OTHER

Sponsor Role collaborator

Umi Sjarqiah

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Umi Sjarqiah

Medical Doctor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Umi Sjarqiah, Medical Doctor

Role: PRINCIPAL_INVESTIGATOR

University of Muhammadiyah Jakarta

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Muhammadiyah Jakarta

Jakarta, DKI Jakarta, Indonesia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Indonesia

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

24-10-1593

Identifier Type: -

Identifier Source: org_study_id